$30,000 of JOHNSON & JOHNSON lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Medical supply chain reforms"
You can find more data on corporate lobbying on Quiver Quantitative.
JNJ Congressional Stock Trading
Members of Congress have traded $JNJ stock 20 times in the past 6 months. Of those trades, 17 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $JNJ stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $50,000 on 03/31 and 1 sale worth up to $15,000 on 01/24.
- REPRESENTATIVE LLOYD DOGGETT has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/04, 12/10 and 0 sales.
- REPRESENTATIVE JEFFERSON SHREVE purchased up to $50,000 on 02/24.
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 6 times. They made 6 purchases worth up to $90,000 on 01/24, 01/21, 01/16, 12/12, 11/26, 11/22 and 0 sales.
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 5 times. They made 5 purchases worth up to $75,000 on 01/08, 12/24, 11/25 and 0 sales.
- REPRESENTATIVE KEVIN HERN sold up to $250,000 on 12/31.
- REPRESENTATIVE VIRGINIA FOXX purchased up to $15,000 on 12/06.
- REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 11/08.
- SENATOR TOMMY TUBERVILLE sold up to $50,000 on 10/29.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
JNJ Insider Trading Activity
JNJ insiders have traded $JNJ stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $JNJ stock by insiders over the last 6 months:
- JOSEPH J WOLK (Exec VP, CFO) sold 13,015 shares for an estimated $2,002,878
- ROBERT J DECKER (VP Corporate Controller) sold 6,999 shares for an estimated $1,160,994
- MARK A WEINBERGER purchased 1,000 shares for an estimated $147,220
- TIMOTHY SCHMID (EVP, WW Chair, MedTech) sold 403 shares for an estimated $62,928
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
JNJ Hedge Fund Activity
We have seen 1,445 institutional investors add shares of JNJ stock to their portfolio, and 2,064 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ removed 8,877,281 shares (-35.3%) from their portfolio in Q4 2024, for an estimated $1,283,832,378
- GAMMA INVESTING LLC added 7,185,977 shares (+24450.4%) to their portfolio in Q1 2025, for an estimated $1,191,722,425
- JPMORGAN CHASE & CO added 4,985,149 shares (+14.7%) to their portfolio in Q4 2024, for an estimated $720,952,248
- PINNACLE ASSOCIATES LTD added 4,703,577 shares (+359.8%) to their portfolio in Q4 2024, for an estimated $680,231,305
- LEGAL & GENERAL GROUP PLC removed 4,603,436 shares (-19.9%) from their portfolio in Q4 2024, for an estimated $665,748,914
- JANUS HENDERSON GROUP PLC added 4,559,147 shares (+134.5%) to their portfolio in Q4 2024, for an estimated $659,343,839
- LAZARD ASSET MANAGEMENT LLC removed 3,705,273 shares (-85.3%) from their portfolio in Q4 2024, for an estimated $535,856,581
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
JNJ Analyst Ratings
Wall Street analysts have issued reports on $JNJ in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 01/22/2025
- Cantor Fitzgerald issued a "Overweight" rating on 10/14/2024
- Cowen & Co. issued a "Buy" rating on 10/14/2024
To track analyst ratings and price targets for JNJ, check out Quiver Quantitative's $JNJ forecast page.
JNJ Price Targets
Multiple analysts have issued price targets for $JNJ recently. We have seen 9 analysts offer price targets for $JNJ in the last 6 months, with a median target of $175.0.
Here are some recent targets:
- Vamil Divan from Guggenheim set a target price of $166.0 on 02/03/2025
- Chris Shibutani from Goldman Sachs set a target price of $159.0 on 10/16/2024
- Terence Flynn from Morgan Stanley set a target price of $175.0 on 10/16/2024
- Shagun Singh from RBC Capital set a target price of $181.0 on 10/16/2024
- Joanne Wuensch from Citigroup set a target price of $185.0 on 10/16/2024
- Larry Biegelsen from Wells Fargo set a target price of $166.0 on 10/15/2024
- Rick Wise from Stifel Nicolaus set a target price of $170.0 on 10/15/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
